Sarcomas of the hand: A retrospective series of 26 cases - 24/06/21

Doi : 10.1016/j.otsr.2021.102991

Joannie Thumser ^a,⁎ , Adeline Cambon-Binder ^b, Julien Even ^c, Antoine Babinet ^d, Philippe Anract ^d, David Biau ^d
^a Hôpital privé Armand-Brillard, 3-5, avenue Watteau, 94130 Nogent-sur-Marne, France
^b Sorbonne University, Orthopaedic and Trauma Department, Saint-Antoine Hospital, Paris, France
^c Clinique Internationale du Parc Monceau, Paris, France
^d Paris-Descartes University, Orthopedic and Trauma Department, Cochin Hospital, Paris, France

^⁎Corresponding author.

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Thursday 24 June 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Background

Hand sarcomas frequently suffer from a delayed diagnosis, and the current guidelines for their management are often not followed.

Methods

The objectives of our study were to determine: (1) the rate of inadequate initial treatments; (2) the rates of mortality, recurrence, and complementary excision in a cohort of patients with a sarcoma of the hand who were treated at our reference center between 2000 and 2015.

Results

The series comprised 26 patients (mean age 40 years). Of the 20 patients not initially treated at a reference center, 17 had inadequate initial treatment. Of the six patients treated at our center, one had inadequate initial care. Significantly more patients had inadequate initial care outside a reference center (p=0.0045). The cumulative probabilities of recurrence or metastases at 5 years were 15% and 30%, respectively. Survival by cumulative incidence was 71% at 5 years and 56% at 10 years.